← All indications
Rotator Cuff Injuries
Injuries to the ROTATOR CUFF of the shoulder joint.
Drugs by status
Phase 4 trials (30)
- hydrocodone
- propofol
- acetylcysteine
- oxycodone
- ibuprofen
- gabapentin
- sevoflurane
- ketorolac
- platelet-rich plasma
- vitamin c
- ropivacaine
- acetaminophen
- polydeoxyribonucleotide
- lidocaine
- epinephrine
- rocuronium
- levobupivacaine
- celecoxib
- desflurane
- bupivacaine
- tramadol
- hydromorphone
- collagen
- vecuronium
- triamcinolone
- tranexamic acid
- pregabalin
- sodium chloride
- omeprazole
- dexamethasone
Phase 3 trials (12)
Phase 2 trials (17)
- oxytocin
- oxandrolone
- human fibrin
- chitosan
- betamethasone
- cannabidiol
- bone marrow derived mesenchymal stem cells
- nalbuphine
- estradiol
- trehalose
- diazepam
- allogeneic adipose derived mesenchymal stem cell
- umbilical cord mesenchymal stem cells
- autologous mesenchymal stem cells
- morphine
- clomifene
- autologous adipose-derived mesenchymal stem cells
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (23)
- Nova Scotia Health Authority
- University of Manitoba
- University of Pittsburgh
- Duke University
- Indiana University
- Seoul National University
- St. Luke's-Roosevelt Hospital Center
- Thomas Jefferson University
- Dalhousie University
- University of Chicago
- Pacira Pharmaceuticals
- OrthoCarolina Research Institute
- Orlando Health
- Government of Korea
- Pennsylvania State University
- University of Alabama, Birmingham
- Hallym University
- Government of Canada
- Andrews Research & Education Foundation
- The University of Texas, Dallas
- Rothman Orthopaedics
- Pan Am Clinic
- Sutherland Medical Center
Organization Involved with Phase 3 Indications (13)
- PPD
- Biologische Heilmittel Heel GmbH
- Cerimon Pharmaceuticals
- University of Pennsylvania
- Case Western Reserve University
- Helse Møre og Romsdal HF
- Hospital Italiano de Buenos Aires
- Northwell Health
- University of Alberta
- Central Norway Regional Health Authority
- Ghent University
- Tego Science, Inc.
- Orthopedic Institute, Sioux Falls, SD
Organization Involved with Phase 2 Indications (19)
- Zars Pharma Inc.
- Kessler Foundation
- Henry Ford Health System
- Hospital General Universitario Gregorio Marañon
- Universidad Autonoma de Madrid
- Universidad Complutense de Madrid
- University of Exeter
- University of Southern California
- University of Vermont
- Assiut University
- Zhejiang University
- Asklepieion General Hospital
- Hebrew University
- University of Sao Paulo
- Aretaieion University
- spanish society of orthopedics and traumatology
- Zhejiang Xingyue Biotechnology Co., Ltd.
- University Hospital Motol, Prague, Czech Republilc
- Bioinova, s.r.o.
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (17)
- United States Army
- Chang Gung University
- Haseki Training and Research Hospital
- Loma Linda University
- McMaster University
- Marmara University
- National Cheng Kung University
- Yonsei University
- University of California, San Francisco
- American University of Beirut
- Rush University
- Orlando Orthopaedic Center and Orlando Health, Inc.
- Bezmialem University
- Arthrex, Inc.
- Orthopaedic & Neurosurgery Specialists, Greenwich, CT
- Sanford Orthopedics & Sports Medicine
- L'Institut de Recherche en Chirurgie Orthopédique et Sportive